Phase I Trial of Silymarin for Chronic Liver Diseases

NCT00389376 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

NIH

Sponsor class

Conditions

Hepatitis C
Non-Alcoholic Fatty Liver Disease

Interventions

DRUG: Placebo
DRUG: Silymarin
DRUG: Silymarin
DRUG: Silymarin
DRUG: Silymarin
DRUG: Silymarin
DRUG: Silymarin
DRUG: Silymarin

Sponsor

National Center for Complementary and Integrative Health (NCCIH)

Collaborators

[object Object]